| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |